Landos Biopharma

Landos Biopharma is a clinical-stage biopharmaceutical company based in Blacksburg, VA, United States, that focuses on developing first-in-class, oral therapeutics for patients with autoimmune diseases. The company's research engine has identified novel pathways, including NLRX1 and PLXDC2, which aim to modulate immune responses and metabolism.